Skip to main content

iSpecimen Inc.

corporate_fare Company Profile

iSpecimen Inc.

ISPC·NASDAQ·Industrial Applications And Services·CIK 0001558569

iSpecimen is a technology-driven company that operates a global marketplace platform connecting life science researchers with human biospecimens and associated data. The company was founded to address the challenge of connecting researchers who need human biofluids, tissues, and living cells with the billions of biospecimens available in healthcare provider organizations worldwide that are not easily accessible. Its iSpecimen Marketplace platform aims to transform the biospecimen procurement process by consolidating the buying experience into a single online marketplace. This platform brings together healthcare providers who have biospecimens and researchers from industry, academia, and government institutions who need them. The iSpecimen Marketplace offers single-source access to millions of human biospecimens and patients across a diverse network of specimen providers, facilitating quick and compliant procurement. This solution is designed to save researchers time and money in their specimen procurement process, while also making it easier and more efficient for providers to supply specimens to researchers.

iSpecimen Inc. (NASDAQ:ISPC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors ISPC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • iSpecimen Files S-3 for Resale of 101M Shares, Signaling Over 1000% Dilution and Severe Selling Pressure
  • iSpecimen Amends Series C Preferred Stock Terms for Reverse Stock Split Adjustments
  • iSpecimen Amends Proxy to Lower Annual Meeting Quorum Requirement After Prior Adjournment
  • iSpecimen Registers Resale of 1.56M Shares from Private Placement; Company Faces Going Concern Doubts and Nasdaq Non-Compliance
  • iSpecimen Secures $5.5M in Highly Dilutive Preferred Stock Offering, Mandates Reverse Stock Split Triggers

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.93M
Net Income
-$10.49M
Diluted EPS
-$2.28
Op. Cash Flow
-$4.24M
Free Cash Flow
-$4.24M
Gross Profit
$215.66K
Operating Income
-$8.98M
Cash & Equivalents
$6.88M
Debt / Equity
0.00×
Net Margin
-5.44×
Shares Outstanding
8.48M sh
Source: 10-K · filed 2026-04-01 · accession 0001213900-26-038607
$1.99
52-week range · as of 2026-07-17 $1.99 – $127.2
Market cap
$3.03M
Volume
47.5K (0.5× avg)
3-mo avg 98.3K
Live data · 2026-07-27 19:47 UTC · Market open

show_chartPrice Chart

Loading chart...

feed ISPC - Filings & News (Page 2)

ISPC
Jan 16, 2026, 5:44 PM EST
Filing Type: S-3
Importance Score:
9
Price at Filing: $0.3701
Real-time Price: $1.99 info
Change: Reverse Stock Split info
Market Cap: $3.029M info
ISPC
Jan 16, 2026, 4:05 PM EST
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $0.355
Real-time Price: $1.99 info
Change: Reverse Stock Split info
Market Cap: $3.029M info
ISPC
Jan 06, 2026, 4:30 PM EST
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $0.30165
Real-time Price: $1.99 info
Change: Reverse Stock Split info
Market Cap: $3.029M info
ISPC
Jan 02, 2026, 4:31 PM EST
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.2801
Real-time Price: $1.99 info
Change: Reverse Stock Split info
Market Cap: $3.029M info
ISPC
Jan 02, 2026, 5:03 PM EST
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.2757
Real-time Price: $1.99 info
Change: Reverse Stock Split info
Market Cap: $3.029M info
ISPC
Jan 05, 2026, 5:17 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.3195
Real-time Price: $1.99 info
Change: Reverse Stock Split info
Market Cap: $3.029M info
ISPC
Jan 05, 2026, 5:18 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3195
Real-time Price: $1.99 info
Change: Reverse Stock Split info
Market Cap: $3.029M info